| Position | Action |
|---|---|
| Current position | Maintain current position size unchanged |
| At $180-182 with RSI<35 confirmation | Scale in 5% tranche |
| At $174-178 capitulation zone with >15M volume | Scale in additional 5% |
| Rally toward $190-191.50 (VWMA/Bollinger mid resistance) | Trim position |
CVX is mispriced at current levels with a PEG of 0.73, 24.8% expected EPS growth, a 20-year Microsoft AI power deal providing structural EBITDA support, and a 3.76% dividend yield—all supported by a 0.49 beta defensive profile and $12 above the 200-day moving average.
| Indicator | Value | Signal |
|---|---|---|
| Close | 186.56 | — |
| 10 EMA | 189.47 | bearish |
| 50 SMA | 182.85 | bullish |
| 200 SMA | 174.38 | bullish |
| RSI(14) | 49.66 | neutral |
| Bollinger Middle | 189.21 | bearish |
| Bollinger Upper | 198.16 | bullish |
| Bollinger Lower | 180.25 | bearish |
| MACD | 2.36 | bearish |
| MACD Signal | 3.03 | bearish |
| MACD Histogram | -0.67 | bearish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Hold CVX at $186; balanced risk/reward with defined scale-in zones at $180-182 and $174-178
Maintain current position size unchanged. No aggressive buying at $186. No aggressive selling given 200 SMA structural support. Light hedge layer (XLE puts or partial collar) is appropriate insurance against election-cycle and oil normalization tail risks but not full defensive posture. The position is correctly calibrated for a multi-week to multi-month hold pending Q3 2026 earnings clarity and oil price stabilization around either the bull's $80+ thesis-sustaining level or the bear's $65 normalization target.
When: $174-178 (200 SMA at $174.38) with >15M volume
Then: Scale in additional 5%
↩ rebuts: “Bear Argument #3 (Iran/Hormuz normalization will crush oil prices)”
· concedes: RSI at 49.7 and MACD bearish crossover are valid short-term technical concerns; Q2 sequential EPS jump from ~$1.40/quarter to $6.11 is dramatic and warrants scrutiny; Net debt increased from $29.5B to $45.4B is a legitimate concern; Political rhetoric risk is real in tone if not fundamental
CVX is a cyclical commodity producer priced at a peak-multiple based on a one-quarter oil spike, with deteriorating momentum, working capital concerns, macro headwinds from Hormuz normalization, a transformational but ignored Q3 2025 balance sheet event with 17% dilution, and political tail risk in an election year — making the stock a Hold at best, with asymmetric downside risk.
· concedes: CVX has structural strengths: 200 SMA at $174.38, 0.49 beta, dividend yield, and capital return program are real; Not calling for a collapse — the Q2 EPS print did happen and will provide some support; The integrated model provides stability and smooths volatility relative to pure E&P names; Dividend yield provides some floor support; Beta of 0.49 offers some downside protection in a broad market selloff
→ vs conservative: Normalizing EPS to $5.76 anchors on pre-deal, pre-cycle peak earnings and ignores that Q2 2026's $6.11 print represents the new reality, not an anomaly to be averaged away
→ vs conservative: Technical bearish signals (MACD cross, RSI at 49.66, VWMA distribution) are being overemphasized; price is still 7% above 200 SMA at $174.38 which has been a durable floor since early 2025 and the pullback is consolidation, not breakdown
→ vs conservative: The oil normalization thesis is too bearish; even if Hormuz normalizes, structural shift of US importing zero Saudi crude for first time in 41 years benefits CVX regardless of spot price, and even $60 WTI generates massive FCF
→ vs conservative: Political risk is being overweighted; Trump rhetoric is election-cycle noise, not legislative reality, and there is no actual windfall tax bill proposed
→ vs conservative: Waiting for capitulation AND clean reclaim of $191.50 with RSI >55 and MACD bullish cross before engaging is asking for confirmation on both sides; the 200 SMA at $174.38 is a generational support level with the 3.76% yield floor underneath it with structurally limited downside
→ vs neutral: Waiting for $191.50 confirmation is performance anxiety dressed up as discipline; anyone waiting will chase the next leg higher at $200+
| ATR(14) |
| 4.37 |
| — |
| VWMA | 191.50 | bearish |
| Volume (today) | 4.92 M | — |
Support: 182.85 · 180.25 · 174.38 | Resistance: 189.47 · 191.5 · 198.16
Technical analysis of CVX shows a stock in short-term pullback (below 10 EMA and VWMA) but maintaining long-term bullish structure (well above 200 SMA). Momentum indicators (RSI 49.66, MACD bearish crossover with histogram -0.67) signal caution. The composite bias is Neutral/Hold with resistance at $189.47 (10 EMA), $191.50 (VWMA), and $198.16 (BB upper); support at $182.85 (50 SMA), $180.25 (BB lower), and $174.38 (200 SMA). A bullish resolution requires reclaiming $189-$191 on volume >8M shares; a bearish breakdown targets $180 then $174.
Market Cap
~$366.0 Billion
PE Ratio (TTM)
17.96
Forward PE
14.39
PEG Ratio
0.73
Price to Book
2.01
EPS (TTM)
$10.39
Forward EPS
$12.97
Dividend Yield
3.76%
Beta
0.488
52-Week High
$214.71
52-Week Low
$146.49
50-Day MA
$182.79
200-Day MA
$175.58
Book Value/Share
$92.91
Revenue TTM
$209.4B
Net Income TTM
$20.6B
Profit Margin TTM
9.84%
Operating Margin TTM
21.95%
Q2 2026 Revenue
$47.56B
Q2 2026 Gross Profit
$13.48B
Q2 2026 Operating Income
$3.22B
Q2 2026 Net Income
$2.21B
Q2 2026 Diluted EPS
$6.11
Q1 2026 Revenue
$45.79B
Q1 2026 Gross Profit
$14.56B
Q1 2026 Operating Income
$4.02B
Q1 2026 Net Income
$2.77B
Q1 2026 Diluted EPS
$1.11
Q4 2025 Revenue
$48.17B
Q4 2025 Gross Profit
$14.99B
Q4 2025 Operating Income
$4.30B
Q4 2025 Net Income
$2.77B
Q4 2025 Diluted EPS
$1.39
Q3 2025 Revenue
$44.38B
Q3 2025 Gross Profit
$13.17B
Q3 2025 Operating Income
$4.06B
Q3 2025 Net Income
$3.54B
Q3 2025 Diluted EPS
$1.82
Q2 2025 Revenue
$46.10B
Q2 2025 Gross Profit
$13.37B
Q2 2025 Operating Income
$4.30B
Q2 2025 Net Income
$2.49B
Q2 2025 Diluted EPS
$1.45
Q1 2026 Total Assets
$329.6B
Q1 2026 Total Liabilities
$140.2B
Q1 2026 Stockholders' Equity
$183.7B
Q1 2026 Total Debt
$45.4B
Q1 2026 Net Debt
$40.1B
Q1 2026 Cash & Equivalents
$5.3B
Q1 2026 Working Capital
$4.0B
Q1 2026 Net PPE
$218.1B
Q1 2026 Inventory
$10.6B
Q1 2026 Receivables
$25.3B
Goodwill
$4.57B
Long-term Debt
$39.6B
Current Portion of Debt
$5.8B
Debt to Equity
23.99%
Q1 2026 Operating Cash Flow
$2.51B
Q1 2026 CapEx
($4.06B)
Q1 2026 Free Cash Flow
($1.55B)
Q1 2026 Dividends Paid
($3.53B)
Q1 2026 Buybacks
($2.57B)
Q1 2026 Debt Issued (net)
+$4.64B
Q1 2026 Net Income (Cont.)
$2.29B
Q4 2025 OCF
$10.79B
Q4 2025 FCF
$5.53B
Q3 2025 OCF
$9.39B
Q3 2025 FCF
$4.94B
Q2 2025 OCF
$8.58B
Q2 2025 FCF
$4.86B
Q1 2025 OCF
$5.19B
Q1 2025 FCF
$1.26B
Depreciation & Amortization
~$5.8B/quarter (~$23B annual)
Total Capital Return (Quarterly avg)
~$5–6B
TTM Dividends
~$14B
TTM Buybacks
~$11B
TTM Free Cash Flow (excl. WC-distorted Q1 2026)
~$16–18B
Strengths
Concerns
Chevron Corporation (CVX) is a fundamentally sound integrated energy major with a forward P/E of 14.39×, expected 25% EPS growth, and a PEG ratio of 0.73 indicating value + growth characteristics, supported by a 3.76% dividend yield and defensive beta of 0.49. A major balance sheet expansion occurred in Q3 2025 (+$75.7B in assets, likely M&A) with share count increasing to ~2.0B, fundamentally changing CVX's scale. The most critical red flags requiring investigation are: (1) Q2 2026 EPS of $6.11 which is 5x the normalized quarterly run-rate and may reflect one-time gains, (2) Q1 2026 negative FCF due to a $7.2B receivables build, and (3) gross margin compression in 2026 despite stable $44–48B quarterly revenue.